Partners Ekwan Rhow and Ariel Neuman have been recognized in the Daily Journal’s 2026 list of Leading Commercial Litigators. The annual list honors the top attorneys who excel in complex business disputes and bet-the-company litigation across the country. This year marks the second consecutive year that Mr. Rhow and Mr. Neuman have been recognized in this category together, following Mr. Rhow’s initial inclusion in the list’s inaugural 2023 issue. Both partners are also Fellows of the American College of Trial Lawyers, a distinct honor held by less than 1% of all practicing lawyers.
A nationally renowned trial lawyer, name partner Ekwan Rhow is widely respected for his impressive success at the forefront of cutting-edge and high-stakes litigation. Mr. Rhow most recently led his trial team to secure a landmark jury verdict awarding over $510 million in damages to Saint Mary’s Health Network – one of the largest verdicts in healthcare litigation history. He and his Bird Marella team are also spearheading a series of cutting-edge national class actions in federal district courts around the country that attack the data privacy policies and interception of private data by companies such as Microsoft, TikTok, Capital One, and Blue Shield.
Mr. Neuman is recognized as one of the nation’s top trial attorneys who clients turn to for their most high-profile civil cases and criminal investigations. His expertise in both commercial litigation and white-collar defense provides a significant edge, enabling him to adeptly manage his clients’ most critical cases with strategic insight and a comprehensive tactical approach. He regularly represents some of the world’s largest companies in both criminal and civil matters, including serving as lead trial counsel for multi-firm teams. Some of his greatest successes are those which never become public.
Click here to view the Leading Commercial Litigators list (Daily Journal subscription required).
